# immune-path

**Canonical:** https://apis.io/providers/immune-path/  
**Website:** https://immune-path.com  
**APIs profiled:** 0

Immune-Path (Yidao Biotechnology (Suzhou) Co., Ltd. / 怡道生物) is a China-based vaccine biotechnology company founded in 2017 and headquartered in Suzhou. The company develops human vaccines across recombinant protein antigen, novel viral vector, and messenger RNA (mRNA) platforms, backed by its own vaccine adjuvant technology. Its clinical and preclinical pipeline includes a recombinant zoster (shingles) vaccine produced in CHO cells, a nine-valent recombinant HPV vaccine expressed in Pichia pastoris, a respiratory syncytial virus (RSV) vaccine, a therapeutic gastric cancer vaccine, and a COVID-19 vaccine. Immune-Path is a portfolio company of Qiming Venture Partners. It is a life-sciences drug developer with no public developer, API, or software surface; this profile is maintained as a company record in the API Evangelist network.

## Kin Score — 2.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 2.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biotechnology, Vaccines, Immunology, Pharmaceuticals, Life Sciences, Drug Development, mRNA, Healthcare, China

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/immune-path/). Scores are computed from the provider's own public artifacts under a published rubric.